文献速递糖尿病

2021年ADA糖尿病诊疗标准:血糖治疗的药物方法

9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2021.
PubMed 文献 · Diabetes Care · 2021-01-01

美国糖尿病协会(ADA)发布2021年糖尿病诊疗标准,其中第9部分聚焦血糖治疗的药物方法。该标准由ADA专业实践委员会多学科专家团队制定并每年更新,提供糖尿病诊疗的推荐意见、治疗目标与质量评估工具。

要点

  • ADA标准每年更新,基于最新证据提供糖尿病诊疗推荐。
  • 血糖药物治疗需遵循标准中的推荐意见与治疗目标。
  • 标准包含质量评估工具,用于评价医疗服务质量。

核心结论

  • ADA标准提供当前临床实践推荐,包括糖尿病诊疗组件、总体治疗目标与指南。

研究设计与样本

  • 由ADA专业实践委员会(多学科专家委员会)制定,每年或根据需要更频繁更新。

临床怎么用

  • 临床医生应参照该标准进行血糖治疗的药物选择与管理。
  • 可使用标准中的工具评估糖尿病医疗服务质量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The American Diabetes Association (ADA) "Standards of Medical Care in Diabetes" includes the ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee (https://doi.org/10.2337/dc21-SPPC), are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations, please refer to the Standards of Care Introduction (https://doi.org/10.2337/dc21-SINT). Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2021. Diabetes Care. 2021. PMID: 33298420. doi:10.2337/dc21-S009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。